Reference SummaryMurphy ED, 1966;():521-62
Title |
Characteristic Tumors | ||||||||||||||||||||
Authors |
Murphy ED | ||||||||||||||||||||
Journal |
|||||||||||||||||||||
Volume |
|||||||||||||||||||||
Issue |
|||||||||||||||||||||
Year |
1966 | ||||||||||||||||||||
Pages |
521-62 | ||||||||||||||||||||
Abstract |
|||||||||||||||||||||
Links |
J:24830 – MGI References |
||||||||||||||||||||
Strain Notes
|
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
WB/Re | Adipose tissue liposarcoma | Adipose tissue |
observed |
||
DBA | Adrenal gland - Cortex hyperplasia - nodular | Adrenal gland - Cortex |
observed |
||
CE/J | Adrenal gland - Cortex tumor |
|
Adrenal gland - Cortex |
100 |
|
CE/J | Adrenal gland - Cortex tumor |
|
Adrenal gland - Cortex |
79 |
|
C3HeB/De | Adrenal gland - Cortex tumor | Adrenal gland - Cortex |
4.8 |
||
DBA/2eBDe | Adrenal gland - Cortex tumor | Adrenal gland - Cortex |
1.3 |
||
CE | Adrenal gland - Cortex tumor | Adrenal gland - Cortex |
observed |
||
(DBA x CE)F1 | Adrenal gland - Cortex tumor | Adrenal gland - Cortex |
observed |
||
BALB/c | Adrenal gland - Cortex tumor | Adrenal gland - Cortex |
observed |
||
NH | Adrenal gland - Cortex tumor | Adrenal gland - Cortex |
observed |
||
CBA | Adrenal gland - Cortex tumor | Adrenal gland - Cortex |
observed |
||
C3H | Adrenal gland - Cortex tumor | Adrenal gland - Cortex |
observed |
||
A | Adrenal gland - Cortex tumor | Adrenal gland - Cortex |
observed |
||
C3HeB/De | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
1.2 |
||
wild mice | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
1.9 - 2.8 |
||
(C3H x I)F1 | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
observed |
||
HR/De Hrhr/+ | Blood vessel hemangioendothelioma | Blood vessel |
24 |
||
C3HeB/De | Blood vessel hemangioendothelioma | Blood vessel |
1.2 - 5.2 |
||
C3Hf/He | Blood vessel hemangioendothelioma | Blood vessel |
2 - 3.0 |
||
C57BL/He | Blood vessel hemangioendothelioma | Blood vessel |
2.0 |
||
DBA/2eBDe | Blood vessel hemangioendothelioma | Blood vessel |
12 - 16 |
||
HR/De Hrhr/? | Blood vessel hemangioendothelioma | Blood vessel |
14 - 29 |
||
wild mice | Blood vessel hemangioendothelioma | Blood vessel |
2.8 - 8.1 |
||
C3Hf/He | Bone osteosarcoma | Bone |
1 - 1 |
||
wild mice | Bone osteosarcoma | Bone |
1.4 |
||
(BALB/c x C3H)F1 | CNS - Brain - Undifferentiated cell glioblastoma | CNS - Brain - Undifferentiated cell |
observed |
||
C57BL | CNS - Brain - Undifferentiated cell medulloblastoma | CNS - Brain - Undifferentiated cell |
observed |
||
C57BL | CNS - Brain glioma | CNS - Brain |
observed |
||
C57BL/He | Clitoral gland tumor | Clitoral gland |
1 |
||
C3H/He | Eye - Harderian gland tumor | Eye - Harderian gland |
1 |
||
C3HeB/De | Eye - Harderian gland tumor | Eye - Harderian gland |
4.8 |
||
DBA/2eBDe | Eye - Harderian gland tumor | Eye - Harderian gland |
2.0 |
||
HR/De Hrhr/? | Eye - Harderian gland tumor | Eye - Harderian gland |
2.1 |
||
BALB/c | Kidney adenocarcinoma | Kidney |
40 |
||
C3Hf/He | Kidney carcinoma | Kidney |
1 |
||
C3HeB/De | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell tumor | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
1.2 |
||
DBA/2eBDe | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell tumor | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
1.3 |
||
C3H | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell tumor | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
observed |
||
AKR/Lw | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
92 |
||
C58/Lw | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
90 |
||
C3HeB/De | Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte |
1.0 |
||
C3Hf/He | Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte |
1 |
||
C57BL/He | Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte |
3.0 |
||
DBA/2eBDe | Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte |
2.6 - 7.8 |
||
HR/De Hrhr/? | Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte |
5.8 - 7.9 |
||
wild mice | Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte |
2.0 |
||
AKR | Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte |
high |
||
C58 | Leukocyte - Lymphocyte lymphohematopoietic neoplasm | Leukocyte - Lymphocyte |
high |
||
C57BL/He | Leukocyte - Lymphocyte reticulum cell neoplasm, type A | Leukocyte - Lymphocyte |
15 |
||
C3HeB/De | Leukocyte - Lymphocyte reticulum cell neoplasm, type A | Leukocyte - Lymphocyte |
0.6 - 2.0 |
||
DBA/2eBDe | Leukocyte - Lymphocyte reticulum cell neoplasm, type A | Leukocyte - Lymphocyte |
9.8 - 12 |
||
HR/De Hrhr/? | Leukocyte - Lymphocyte reticulum cell neoplasm, type A | Leukocyte - Lymphocyte |
3.2 - 6.3 |
||
wild mice | Leukocyte - Lymphocyte reticulum cell neoplasm, type A | Leukocyte - Lymphocyte |
1 |
||
C57BL | Leukocyte - Lymphocyte reticulum cell neoplasm, type A | Leukocyte - Lymphocyte |
15.0 - 20.0 |
||
SJL/J | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
high - 91 |
||
C3HeB/De | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
1.9 |
||
C57BL/He | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
11 |
||
DBA/2eBDe | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
7.9 - 18 |
||
HR/De Hrhr/? | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
1.9 - 6.3 |
||
wild mice | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
5.0 - 12 |
||
C57L/He | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
25 |
||
wild mice | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell tumor | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell |
1.0 |
||
DBA/2eBDe | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
1.3 - 2.0 |
||
RF | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic |
|
Leukocyte - Myelocyte (Granulocyte) |
observed |
|
C3HeB/De | Liver hepatoma | Liver |
30 - 91 |
||
C3Hf/He | Liver hepatoma | Liver |
17 - 25 |
||
C57BL/He | Liver hepatoma | Liver |
1 |
||
DBA/2eBDe | Liver hepatoma | Liver |
5.3 |
||
HR/De Hrhr/? | Liver hepatoma | Liver |
1.6 - 12 |
||
wild mice | Liver hepatoma | Liver |
2.8 - 9.3 |
||
C3H | Liver hepatoma | Liver |
moderate |
||
CBA | Liver hepatoma | Liver |
moderate |
||
C3H/He | Liver hepatoma | Liver |
85 |
||
C3HeB | Liver hepatoma | Liver |
58 - 91 |
||
A | Lung - Alveolus tumor | Lung - Alveolus |
high |
||
SWR | Lung - Alveolus tumor | Lung - Alveolus |
high |
||
BALB/c | Lung - Alveolus tumor | Lung - Alveolus |
high |
||
A | Lung tumor | Lung |
90 |
||
SWR | Lung tumor | Lung |
80 |
||
C3HeB/De | Lung tumor | Lung |
3.7 - 24 |
||
C3Hf/He | Lung tumor | Lung |
6.0 - 10 |
||
C57BL/He | Lung tumor | Lung |
1.0 |
||
DBA/2eBDe | Lung tumor | Lung |
3.9 |
||
HR/De Hrhr/? | Lung tumor | Lung |
3.2 - 17 |
||
wild mice | Lung tumor | Lung |
15 - 28 |
||
C3HeB/De | Mammary gland adenoacanthoma | Mammary gland |
17 - 28 |
||
C3Hf/He | Mammary gland adenoacanthoma | Mammary gland |
9.6 |
||
C3HeB/De | Mammary gland adenocarcinoma - type A | Mammary gland |
17 - 26 |
||
C3Hf/He | Mammary gland adenocarcinoma - type A | Mammary gland |
18 |
||
wild mice | Mammary gland adenocarcinoma - type A | Mammary gland |
3.0 |
||
C3H | Mammary gland adenocarcinoma - type A |
|
Mammary gland |
observed |
|
C3HeB/De | Mammary gland adenocarcinoma - type B | Mammary gland |
4.0 - 28 |
||
C3Hf/He | Mammary gland adenocarcinoma - type B | Mammary gland |
19 |
||
DBA/2eBDe | Mammary gland adenocarcinoma - type B | Mammary gland |
5.9 |
||
wild mice | Mammary gland adenocarcinoma - type B | Mammary gland |
2.0 |
||
DBA/2eBDe | Mammary gland adenocarcinoma - type C | Mammary gland |
2.6 |
||
C3HeB/De | Mammary gland carcinoma | Mammary gland |
4.0 - 74 |
||
C3Hf/He | Mammary gland carcinoma | Mammary gland |
2 - 40 |
||
HR/De Hrhr/? | Mammary gland carcinoma | Mammary gland |
4.2 - 30 |
||
wild mice | Mammary gland carcinoma | Mammary gland |
6.1 |
||
C3H/He | Mammary gland tumor | Mammary gland |
99 - 100 |
||
DBA/2 | Mammary gland tumor | Mammary gland |
77 - 77 |
||
A | Mammary gland tumor | Mammary gland |
5 - 84 |
||
DD/He | Mammary gland tumor | Mammary gland |
75 - 84 |
||
C3H | Mammary gland tumor | Mammary gland |
high |
||
DBA | Mammary gland tumor | Mammary gland |
moderate - high |
||
DD | Mammary gland tumor | Mammary gland |
high |
||
H | Mammary gland tumor | Mammary gland |
observed - high |
||
C3HeB/De | Mammary gland tumor - mixed | Mammary gland |
0.6 - 4.9 |
||
C3H/J | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
3 |
||
C3HeB/De | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
1.2 - 7.1 |
||
C3HeB/De | Mesodermal cell/mesoblast sarcoma | Uterus |
3.0 |
||
C3Hf/He | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
3 |
||
C3Hf/He | Mesodermal cell/mesoblast sarcoma | Uterus |
2 |
||
C57BL/He | Mesodermal cell/mesoblast sarcoma | Uterus |
1 |
||
DBA/2eBDe | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
3.9 |
||
DBA/2eBDe | Mesodermal cell/mesoblast sarcoma | Uterus - Endometrium |
2.0 |
||
HR/De Hrhr/? | Mesodermal cell/mesoblast sarcoma | Uterus |
2.1 - 3.2 |
||
HR/De Hrhr/? | Mesodermal cell/mesoblast sarcoma | Mammary gland |
1.6 |
||
wild mice | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
1.4 - 2.0 |
||
C3H | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
observed |
||
C3Hf | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
observed |
||
C57BL | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
0 |
||
(DED2F1 x DBA/2WyDi) | Mesodermal cell/mesoblast sarcoma | CNS - Meninges |
observed |
||
DBA/2eBDe | Muscle - Smooth leiomyoma | Uterus |
1.3 |
||
BALB/c | Myoepithelial cell myoepithelioma | Salivary gland - Parotid |
4 |
||
A | Myoepithelial cell myoepithelioma | Salivary gland - Parotid |
4 |
||
C3HeB/De | Myoepithelial cell myoepithelioma | Myoepithelial cell |
1.2 |
||
HR/De Hrhr/? | Myoepithelial cell myoepithelioma | Myoepithelial cell |
1.6 |
||
C58 | Myoepithelial cell myoepithelioma | Salivary gland - Parotid |
observed |
||
C3H | Ovary - Germ cell teratoma | Ovary - Germ cell |
observed |
||
C3H/J | Ovary - Germ cell teratoma | Ovary - Germ cell |
observed |
||
C3HeB/De | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
13 - 23 |
||
C57BL/He | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
1 |
||
HR/De Hrhr/? | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
2.1 - 4.8 |
||
wild mice | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
2.8 - 6.1 |
||
C3HeB/De | Ovary adenoma - tubular | Ovary |
14 - 25 |
||
HR/De Hrhr/? | Ovary cystadenoma - papillary | Ovary |
1.6 - 2.1 |
||
C3HeB/De | Ovary luteoma | Ovary |
0.6 - 2.0 |
||
C3HeB/De | Ovary tumor | Ovary |
29 - 47 |
||
C3HeB/Fe | Ovary tumor | Ovary |
22 - 64 |
||
RIII | Ovary tumor | Ovary |
50 - 60 |
||
CE/Wy | Ovary tumor | Ovary |
34 |
||
C3Hf/He | Ovary tumor | Ovary |
6.0 - 8 |
||
CE | Ovary tumor | Ovary |
34 |
||
C3HeB/FeJ | Ovary tumor | Ovary |
64 |
||
RIII/J | Ovary tumor | Ovary |
60 |
||
C3Hf/He | PNS - Schwann cell myoblastoma - granular cell | PNS - Schwann cell |
1 |
||
C3H | PNS - Schwann cell myoblastoma - granular cell | PNS - Schwann cell |
observed |
||
(C3Hf x I)F1 | Pancreas - Islet of Langerhans - Beta cell hyperplasia | Pancreas - Islet of Langerhans - Beta cell |
high |
||
(C3Hf x I)F1 | Pancreas - Islet of Langerhans - Beta cell tumor | Pancreas - Islet of Langerhans - Beta cell |
high |
||
HR/De Hrhr/? | Pancreas - Islet of Langerhans tumor | Pancreas - Islet of Langerhans |
1.6 |
||
C57L | Pituitary gland tumor | Pituitary gland |
3.5 - 33 |
||
C57BR/cd | Pituitary gland tumor | Pituitary gland |
33 |
||
(L x A)F1 | Pituitary gland tumor | Pituitary gland |
1 |
||
C57L/J | Pituitary gland tumor | Pituitary gland |
33 |
||
C57BR/cdJ | Pituitary gland tumor | Pituitary gland |
33 |
||
CE | Pituitary gland tumor | Pituitary gland |
observed |
||
C57BL/6 | Pituitary gland tumor | Pituitary gland |
observed |
||
DBA | Skin - Melanocyte melanoma | Skin - Melanocyte |
very low |
||
HR/De Hrhr | Skin carcinoma | Skin |
3 |
||
HR/De Hrhr | Skin papilloma | Skin |
9 - low |
||
C3HeB/De | Skin papilloma | Skin |
0.6 |
||
C3Hf/He | Skin papilloma | Skin |
1 |
||
HR/De Hrhr/? | Skin papilloma | Skin |
1.6 - 3.8 |
||
HR/De Hrhr/+ | Skin papilloma | Skin |
low |
||
C3HeB/De | Skin squamous cell carcinoma | Skin |
0.6 |
||
C3Hf/He | Skin squamous cell carcinoma | Skin |
1 |
||
C57BL/He | Skin squamous cell carcinoma | Skin |
1 |
||
HR/De Hrhr/? | Skin squamous cell carcinoma | Skin |
1.6 - 5.8 |
||
HR/De Hrhr | Skin squamous cell carcinoma | Skin |
low |
||
HR/De Hrhr/+ | Skin squamous cell carcinoma | Skin |
low |
||
129 | Testis - Germ cell teratoma | Testis - Germ cell |
1 |
||
129 | Testis - Germ cell teratoma |
|
Testis - Germ cell |
82 |
|
wild mice | Testis - Germ cell teratoma | Testis - Germ cell |
1.9 |
||
129.C3-KitlSl | Testis - Germ cell teratoma | Testis - Germ cell |
10 |
||
H | Testis - Leydig cell (Interstitial cell) hyperplasia | Testis - Leydig cell (Interstitial cell) |
observed |
||
BALB/c | Testis - Leydig cell (Interstitial cell) hyperplasia | Testis - Leydig cell (Interstitial cell) |
observed |
||
C | Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) |
observed |
||
BALB/c | Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) |
observed |
||
RF | Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) |
observed |
||
H | Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) |
observed |
||
BALB/c | Testis - Leydig cell (Interstitial cell) tumor |
|
Testis - Leydig cell (Interstitial cell) |
observed |
|
A | Testis - Leydig cell (Interstitial cell) tumor |
|
Testis - Leydig cell (Interstitial cell) |
observed |
|
C3Hf/He | Urinary bladder papilloma | Urinary bladder |
1 |
||
HR/De Hrhr/? | Uterus adenocarcinoma | Uterus |
1.6 |
||
BALB/c | Uterus adenocarcinoma | Uterus |
observed |
||
(C3H x C57BL)F1 | Uterus adenocarcinoma | Uterus |
observed |
||
129P3/J | Vulva papilloma | Vulva |
observed |
||
129P3/J | Vulva squamous cell carcinoma | Vulva |
observed |
||
C3Hf/He | (Unspecified organ) tumor | (Unspecified organ) |
3.0 |